Abstract #3947
Evaluation of a Cerebral-Blood-Volume (CBV) pharmaco-MRI (phMRI) Assay Utilizing Low (0.1mg/70kg) and High (0.2mg/70kg) Dose Buprenorphine Infusion and a Novel USPIO Contrast Agent (Ferumoxytol) in Healthy Human Subjects.
Richard Baumgartner 1 , Arie Struyk 2 , Jeff Evelhoch 2 , Cynthia Gargano 2 , Francheska Colon Gonzalez 2 , Haiying Liu 1 , Ruben Declercq 3 , Hans Verheyden 3 , Ingeborg Heirman 3 , Hans De Pla 4 , Griet Van Lancker 4 , Sofie Van den Abeele 4 , Adelheid Hollebosch 4 , Brant Delafontaine 4 , Luc Van Bortel 4 , Rik Achten 4 , Patricia Clement 4 , Pieter Vandemaele 4 , Dai Feng 1 , and Sofia Apreleva 1
1
Merck and Co, Rahway, New Jersey, United
States,
2
Merck
and Co, Pennsylvania, United States,
3
Merck
and Co, Belgium,
4
Ghent
University, Belgium
We present results from a clinical trial of pharmaco-MRI
(phMRI) employing cerebral blood volume (CBV) imaging
using ferumoxytol (Rienso/Feraheme, AMAG) as a blood
pool contrast agent. The study examined the
pharmacodynamic effects of two single doses of
buprenorphine (0.2mg/70kg and 0.1mg/70kg administered
intravenously). We found that contrast-enhanced CBV
phMRI signals are more sensitive reporters of
pharmacodynamic effects than conventional blood oxygen
level dependent (BOLD) phMRI. In particular, higher
sensitivity of CBV phMRI compared to BOLD allows for
elucidation of PD responses at lower doses of
buprenorphine, which has practical implications for
similar phMRI studies with centrally acting drugs.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
